13F-HR filed by GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-14, with 37 holding rows worth $673,402,000.
- Accession
- 0000930413-18-001815
- Filer
- CIK 1281446
- Filed
- 2018-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2018
A holdings report, 38 entries on the cover page, a total value of $673,402,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $673,402,000 with VALUE read as dollars, detected, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJAY JEFFREY R028-12517
- included managerKROIN DAVID028-13262
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 3,321,173 | $56,128,000 | dollars, detected | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 1,305,887 | $51,583,000 | dollars, detected | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 2,380,846 | $44,641,000 | dollars, detected | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 1,539,822 | $41,668,000 | dollars, detected | |
| ZOGENIX INC. | 98978L204 | Common Stock | 978,302 | $39,181,000 | dollars, detected | |
| SPARK THERAPEUTICS INC | 84652J103 | COM | 550,000 | $36,625,000 | dollars, detected | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 7,478,275 | $35,671,000 | dollars, detected | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 736,631 | $35,579,000 | dollars, detected | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 500,000 | $34,025,000 | dollars, detected | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 400,000 | $33,172,000 | dollars, detected | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 8,579,454 | $30,371,000 | dollars, detected | |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 900,579 | $28,665,000 | dollars, detected | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 4,781,708 | $24,530,000 | dollars, detected | |
| EXELIXIS INC COM | 30161Q104 | Stock | 899,900 | $19,933,000 | dollars, detected | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 500,000 | $18,355,000 | dollars, detected | call |
| ACCELERON PHARMA INC | 00434H108 | COM | 462,245 | $18,074,000 | dollars, detected | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 753,481 | $16,426,000 | dollars, detected | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 868,100 | $14,914,000 | dollars, detected | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 3,700,000 | $13,727,000 | dollars, detected | |
| ENDOCYTE INC | 29269A102 | COM | 1,491,500 | $13,558,000 | dollars, detected | |
| CORSICANTO II DESIGNATED ACT | 220485AB2 | NOTE 3.500% 1/2 | 10,000,000 | $11,025,000 | dollars, detected | |
| SAVARA INC | 805111101 | COM | 862,179 | $7,932,000 | dollars, detected | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 1,687,020 | $6,579,000 | dollars, detected | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 2,695,742 | $6,443,000 | dollars, detected | |
| SIERRA ONCOLOGY INC | 82640U107 | COM | 3,111,111 | $6,440,000 | dollars, detected | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 200,000 | $5,412,000 | dollars, detected | call |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 309,800 | $5,220,000 | dollars, detected | |
| ACORDA THERAPEUTICS INC | 00484M106 | COM | 200,000 | $4,730,000 | dollars, detected | put |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 1,096,200 | $3,300,000 | dollars, detected | call |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 1,056,825 | $3,181,000 | dollars, detected | |
| MENLO THERAPEUTICS INC | 586858102 | COM | 52,008 | $1,954,000 | dollars, detected | |
| NEWLINK GENETICS CORP | 651511107 | COM | 233,500 | $1,693,000 | dollars, detected | |
| ANTARES PHARMA INC | 036642106 | COM | 500,000 | $1,100,000 | dollars, detected | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 15,300 | $604,000 | dollars, detected | call |
| ACORDA THERAPEUTICS INC | 00484M106 | COM | 19,000 | $449,000 | dollars, detected | call |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 5,700 | $275,000 | dollars, detected | put |
| STREAMLINE HEALTH SOLUTIONS | 86323X106 | COM | 130,137 | $239,000 | dollars, detected |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000930413-18-001815 | this filing | 2018-05-14 | acceptance time not in the bulk data set |